Endovenous laser ablation for saphenous vein insufficiency: short- and mid-term results of 230 procedures.

Autor:	Altin FH; Department of Cardiovascular Surgery, Diyarbakir Training and Research Hospital, Diyarbakir, Turkey firat3534@yahoo.com., Aydin S; Department of Cardiovascular Surgery, Diyarbakir Training and Research Hospital, Diyarbakir, Turkey., Erkoc K; Department of Cardiovascular Surgery, Diyarbakir Training and Research Hospital, Diyarbakir, Turkey., Gunes T; Department of Cardiovascular Surgery, Diyarbakir Training and Research Hospital, Diyarbakir, Turkey., Eygi B; Department of Cardiovascular Surgery, Diyarbakir Training and Research Hospital, Diyarbakir, Turkey., Kutas BH; Department of Cardiovascular Surgery, Diyarbakir Training and Research Hospital, Diyarbakir, Turkey.
Jazyk:	angličtina
Zdroj:	Vascular [Vascular] 2015 Feb; Vol. 23 (1), pp. 3-8. Date of Electronic Publication: 2014 Feb 19.
DOI:	10.1177/1708538114522997
Abstrakt:	Objective: The present study aimed to evaluate the efficacy of endovenous laser ablation with a 1470-nm laser and to analyze the short- to mid-term results of endovenous laser ablation procedures to treat great saphenous vein insufficiency. Method: In this retrospective study, 200 patients (230 limbs) with symptomatic varicose veins secondary to great saphenous vein insufficiency treated with 1470-nm endovenous laser ablation were studied. Patients were evaluated clinically on the first day, first week, first month, and sixth month after the operation. Treated limbs were evaluated as separate treatment events. Results: The short-term occlusion rate was 99% and mid-term occlusion rate was 100%. Induration or swelling was the most common minor complication (13%). No major complication such as deep venous thrombosis and pulmonary embolus occurred. Preoperatively documented mean venous clinical severity score significantly reduced from 4.9±2.3 to 2.5±1.1 (p<0.05). Conclusion: Endovenous laser ablation procedure of great saphenous vein with a 1470-nm diode laser is a minimally invasive, safe, and efficient treatment option in all-suitable patients with high short- and mid-term success rate. (© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu